<![CDATA[Press Releases: DNA]]>en-us<![CDATA[Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market]]><![CDATA[Technical Trade Alert on Market Movers: YGE, DPS, CAG, RSH, FCS, DNA]]><![CDATA[Roche Completes Acquisition of Genentech]]><![CDATA[Roche Completes Tender Offer for Genentech]]><![CDATA[OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer]]><![CDATA[XplosiveStocks.com: VZ, JNJ, PRU, HPQ, TXN, DNA Hot Stock Alerts!]]><![CDATA[Stock Preacher Issues Technical Trade Alerts on: BAC, C, CVTX, DNA, GE, GM]]><![CDATA[Wall Street News Alert: Investment Alerts: OCOL! March 13, 2009]]><![CDATA[Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation]]><![CDATA[Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint]]><![CDATA[Technical Trade Alerts on Biotechnology Stocks: ASTM, DNA, GILD, GENZ, CELG, ACOR]]><![CDATA[Beacon Equity Issues Technical Trade Alerts on Biotechnology Stocks: ASTM, DNA, GILD, GENZ, CELG, ACOR]]><![CDATA[CytoDyn Responds to FDA as High Court Rules Agency Cannot Guarantee Drug Safety]]><![CDATA[Genentech Urges Shareholders to Take No Action With Respect to Revised Offer From Roche]]><![CDATA[Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer]]><![CDATA[Schaeffer's Street Stories: Call Volume Swarms Genentech, Inc. as the Shares Battle Resistance]]><![CDATA[Genentech Receives Final Notification Upholding Cabilly Patent in Reexamination Proceeding]]><![CDATA[Genentech Announces March 2, 2009 Webcast of Investment Community Meeting]]><![CDATA[Genentech Special Committee Rejects Roche’s $86.50 Offer as Inadequate]]><![CDATA[XplosiveStocks.com: RIG, DNA, CLH, PPDI, SIRF,PSYS Hot Stock Alerts!]]><![CDATA[Seven Summits Research Releases Comments on T, DNA, FSLR, HES, and SWY]]><![CDATA[Genentech Urges Shareholders to Take No Action With Respect to Unsolicited Tender Offer From Roche]]><![CDATA[Roche Drops Genentech Bid to $41 Billion, an Industrial Info News Alert]]><![CDATA[Phase III Study Showed Tarceva in Combination With Avastin as First-Line Maintenance Therapy Improved Progression-Free Survival in Advanced Lung Cancer]]><![CDATA[Beacon Equity Issues Trade Alerts on Newsworthy Market Movers: PG, GCI, AMAT, DDUP, DNA, S]]><![CDATA[Technical Trade Alerts on Market Movers: PG, GCI, AMAT, DDUP, DNA, S]]><![CDATA[Special Committee of Genentech Board of Directors Responds to Roche’s Announced Intention to Commence a Tender Offer]]><![CDATA[Seven Summits Research Releases Comments on AMZN, DNA, V, SPWRA, and IP]]><![CDATA[Stock Preacher Issues Technical Trade Alerts on: SKS, DNA, LCC, CHTR, FNSR, AZO]]><![CDATA[Genentech Announces Vice President Appointment in Research]]>
